Skip to main content

Table 1 Characteristics of the participants according to presence of NAFLD

From: The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease

  Non-NAFLD NAFLD P value
Total, N (%) 6 412 (59.6%) 4 349 (40.4%)
Men, N (%) 3 622 (56.5%) 3 136 (72.1%) <0.0001
Age, years 47.0 (36.0–57.0) 52.0 (43.0–59.0) <0.0001
Body mass index, kg/m2 22.1 (20.4–23.8) 25.6 (24.0–27.4) <0.0001
Systolic blood pressure, mmHg 120.0 (110.0–130.0) 128.0 (120.0–139.0) <0.0001
Diastolic blood pressure, mmHg 75.0 (70.0–80.0) 80.0 (75.0–90.0) <0.0001
Fasting plasma glucose, mmol/L 4.9 (4.6–5.3) 5.2 (4.8–5.8) <0.0001
Triglycerides, mmol/L 0.9 (0.7–1.3) 1.6 (1.1–2.4) <0.0001
Total cholesterol, mmol/L 4.4 (3.8–5.0) 4.8 (4.2–5.4) <0.0001
HDL cholesterol, mmol/L 1.4 (1.2–1.6) 1.2 (1.1–1.4) <0.0001
LDL cholesterol, mmol/L 2.6 (2.2–3.1) 3.0 (2.5–3.5) <0.0001
Uric acid, μmol/L 282.0 (233.0–334.0) 333.0 (284.9–384.6) <0.0001
White blood cell counts, ×109/L 5.5 (4.7–6.5) 6.1 (5.3–7.2) <0.0001
Alanine aminotransferase, U/L 17.0 (13.0–24.0) 26.0 (18.0–37.0) <0.0001
TyG 8.2 (7.8–8.6) 8.8 (8.4–9.3) <0.0001
  1. Data are presented as median (interquartile range) or percentage
  2. TyG indicates the triglycerides and glucose index
  3. NAFLD: nonalcoholic fatty liver disease; HDL; high density lipoprotein; LDL; low density lipoprotein